Screening, identification, and functional analysis of three novel missense mutations in the TRADD gene in children with ALL and ALPS

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 616-620

  Dechant, M J ^a   Scheuerpflug, C G ^a   Pauly, E ^b   Van Der Werff Ten Bosch, J ^c   Debatin, K M ^b,d   Fellenberg, J ^a,e  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Cancer; Mutation; TRADD

Indexed keywords

COMPLEMENTARY DNA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME III; B CELL LEUKEMIA; CELL SURVIVAL; CELL VIABILITY; CHILDHOOD CANCER; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ASSAY; FADD GENE; FLOW CYTOMETRY; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC SCREENING; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TRADD GENE; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; CELL DEATH; CELL SURVIVAL; CHILD; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MICE; MUTATION, MISSENSE; NF-KAPPA B; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TRANSFECTION;

EID: 52249112658     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21672     Document Type: Article

References (38)

1. Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002;7:313-319.
2. Scaffidi C, Kirchhoff S, Krammer PH, et al. Apoptosis signaling in lymphocytes. Curr Opin Immunol 1999;11:277-285.
3. Scheuerpflug CG, Lichter P, Debatin KM, et al. Assignment of TRADD to human chromosome band 16q22 by in situ hybridization. Cytogenet Cell Genet 2001;92:347-348.
4. Hsu H, Shu HB, Pan MG, et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308.
5. Park YC, Ye H, Hsia C, et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 2000;101:777-787.
6. Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002;296:1634-1635.
7. Tada K, Okazaki T, Sakon S, et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 2001;276:36530-36534.
8. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114: 181-190.
9. Fisher MJ, Virmani AK, Wu L, et al. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 2001;7:1688-1697.
10. Knipping E, Debatin KM, Strieker K, et al. Identification of soluble APO-I in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 1995;85:1562-1569.
11. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
12. Dechant MJ, Fellenberg J, Scheuerpflug CG, et al. Mutation analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines. Int J Cancer 2004;109:661-667.
13. Kitada S, Pedersen IM, Schimmer AD, et al. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 2002; 21:3459-3474.
14. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-1349.
15. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001;98:194-200.
16. Shin MS, Kim HS, Lee SH, et al. Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002;21:4129-4136.
17. Park A, Baichwal VR. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD. J Biol Chem 1996;271:9858-9862.
18. Rozenfeld-Granot G, Toren A, Amariglio N, et al. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies. Exp Hematol 2001;29:228-233.
19. Beltinger C, Kurz E, Bohler T, et al. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 1998; 91:3943-3951.
20. Beltinger C, Bohler T, Karawajew L, et al. Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia. Br J Haematol 1998;102:722-728.
21. Hehlgans T, Muller P, Stopfer P, et al. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells. Eur Cytokine Netw 2003;14:103-107.
22. Chinnaiyan AM, O'Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996;274:990-992.
23. Zheng L, Fisher G, Miller RE, et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995;377:348-351.
24. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21: 485-495.
25. Zhang J, Cado D, Chen A, et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mortl. Nature 1998;392:296-300.
26. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001;98:2603-2614.
27. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol 2003;15:325-331.
28. Pauly E, Fritzsching B, Dechant M, et al. Analysis of the CD95 ligand gene in 20 children with autoimmune lymphoproliferative syndrome (ALPS). Blood 2006;108:3622-3623.
29. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004;351:1409-1418.
30. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ 2003;10:124-133.
31. van der Werff ten Bosch J, Otten J, Thielemans K. Autoimmune lymphoproliferative syndrome type III, an indefinite disorder. Leuk Lymphoma 2001;41:501-511.
32. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-615.
33. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495-504.
34. Devin A, Cook A, Lin Y, et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 2000;12:419-429.
35. Wang CY, Mayo MW, Korneluk RG, et al. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
36. Sethi G, Ahn KS, Xia D, et al. Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-kappa B activation and NF-kappa B-regulated antiapoptotic gene products. J Immunol 2007;179:1926-1933.
37. Grech AP. Amesbury M, Chan T, et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 2004;21:629-642.
38. Zapata JM. Krajewska M, Morse HC III, et al. TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci 2004;101:16600-16605.